Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ironwood Pharmaceuticals (IRWD) Non Operating Income: 2010-2025

Historic Non Operating Income for Ironwood Pharmaceuticals (IRWD) over the last 16 years, with Sep 2025 value amounting to -$7.5 million.

  • Ironwood Pharmaceuticals' Non Operating Income rose 9.71% to -$7.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$29.6 million, marking a year-over-year decrease of 7.10%. This contributed to the annual value of -$27.9 million for FY2024, which is 129.90% down from last year.
  • Latest data reveals that Ironwood Pharmaceuticals reported Non Operating Income of -$7.5 million as of Q3 2025, which was up 0.47% from -$7.5 million recorded in Q2 2025.
  • Ironwood Pharmaceuticals' Non Operating Income's 5-year high stood at $6.9 million during Q2 2023, with a 5-year trough of -$10.7 million in Q2 2021.
  • In the last 3 years, Ironwood Pharmaceuticals' Non Operating Income had a median value of -$7.2 million in 2023 and averaged -$4.8 million.
  • Examining YoY changes over the last 5 years, Ironwood Pharmaceuticals' Non Operating Income showed a top increase of 517.38% in 2023 and a maximum decrease of 664.23% in 2023.
  • Over the past 5 years, Ironwood Pharmaceuticals' Non Operating Income (Quarterly) stood at -$10.3 million in 2021, then spiked by 137.75% to $3.9 million in 2022, then slumped by 285.26% to -$7.2 million in 2023, then decreased by 3.69% to -$7.5 million in 2024, then grew by 9.71% to -$7.5 million in 2025.
  • Its Non Operating Income stands at -$7.5 million for Q3 2025, versus -$7.5 million for Q2 2025 and -$7.2 million for Q1 2025.